Investment Objective: AdvisorShares Psychedelics ETF is an investment vehicle . It is currently trading at 21.75 USD.
Portfolio Composition:
The fund is heavily weighted towards
the Healthcare sector (100%)
and markets in
United States (63%),
Canada (16%),
United Kingdom (11%)
.
For a full breakdown of all holdings, see the "Weights" card above.
Income: This is a distributing fund with a current yield of 2.08%.
Yes, it pays an annual dividend of 0.27 USD (2.08% yield).
AdvisorShares Psychedelics ETF is classified as a ETF. You can compare it against its peer in the "Related Symbols" list.
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
| Year | Total Dividends |
|---|---|
| ▸2026 |
1.68 USD
|
| Dec. 29, 2026 (estimated) | 1.6840 |
| ▸2025 |
1.88 USD
|
| Dec. 29, 2025 | 1.6840 |
| Sept. 29, 2025 | 0.0200 |
| June 27, 2025 | 0.0119 |
| March 28, 2025 | 0.1630 |
| ▸2024 |
0.16 USD
|
| Dec. 30, 2024 | 0.0550 |
| Sept. 30, 2024 | 0.1090 |
| ▸2023 |
0.03 USD
|
| Sept. 29, 2023 | 0.0336 |
| ▸2022 |
0.54 USD
|
| Sept. 30, 2022 | 0.5400 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| AdvisorShares Psychedelics ETF | Dec 29, 2025 | Paid | 1.684 USD |
| Split Date | Split Ratio to 1 |
|---|---|
| Sept. 10, 2024 | 1:10 |
Community Discussion